Prior view was $410M-$450M. Guidance reduction is due to the company’s decision to remove any non-migrant municipal population health revenue from its 2025 guidance. Revenue expectations from the company’s Medical Transportation and Payer & Provider businesses and remaining migrant services healthcare work are unchanged.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCGO: